Baxter gets US nod for intravascular antimicrobial:
This article was originally published in Clinica
Executive Summary
A needleless IV connector containing an antimicrobial coating developed by Baxter Healthcare has gained 510(k) clearance from the US FDA. The V-Link Luer-activated device with VitalShield protective coating has been shown to kill 99.9% of pathogens known to cause catheter-related bloodstream infections, including methicillin-resistant Staphylococcus aureus (MRSA). Deerfield, Illinois-based Baxter plans to launch the device in the US in the first half of 2008 and in other markets later in the year.